COVID-19 Therapeutic Trial Synopsis

Overview

A randomized multi-center adaptive clinical trial to evaluate the efficacy and safety of investigational therapeutic agents in combination with standard-ofcare for the treatment of hospitalized patients with novel coronavirus disease (COVID-19).

The trial will be carried out under a Master Protocol to continue across outbreak sites until the scientific questions of interest are addressed.

The trial will be conducted in two stages: the first will be a Pilot Stage and the second will be a Pivotal Stage.